Effects of immunosuppressive therapy on renal prognosis in primary membranous nephropathy
This study demonstrates the efficacy of immunosuppressive therapy in non-low-risk PMN patients. The key factors affecting renal prognosis in patients with different risk levels are emphasized to help provide individualized treatment.
Authors
- Dongli Qi (ORCID: https://orcid.org/0000-0002-6834-4577)
- Qijun Wan (ORCID: https://orcid.org/0000-0002-5039-4015)
- Xun‐Xi Lu (ORCID: https://orcid.org/0000-0002-5118-0377)
- Wangyang Li (ORCID: https://orcid.org/0009-0008-6998-9343)
- Ji Cen
- Mijie Guan (ORCID: https://orcid.org/0009-0001-0412-9480)
- Jia Chen (ORCID: https://orcid.org/0000-0001-6597-8577)
- Xun Qin
- Meifang Shang
- Lin Wei (ORCID: https://orcid.org/0000-0003-2129-1380)
- Yuan Cheng (ORCID: https://orcid.org/0009-0002-3865-5291)
- Hui‐Wei Huang (ORCID: https://orcid.org/0009-0004-4114-0226)
- Shengchun Wu
- Zhe Wei
Institutions
- Riverside Hospital of Guangxi Zhuang Autonomous Region (CN)
- Hechi University (CN)
- Shenzhen Second People's Hospital (CN)
Publication Details
- Journal
- BMC Nephrology
- Published
- 2024-10-24
- DOI
- https://doi.org/10.1186/s12882-024-03796-4
- Citations
- 3
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 1.02
Funders
- Sanming Project of Medicine in Shenzhen